Apple Pro and Tell, Genie 4, The Gurmanator Joins | Mark Gurman, Zach Rash, Ben Liu, Amiram Shachar, Jasper Zhang

Overview

This episode dives into the latest tech and innovation updates, featuring discussions on Apple's new product launches, Google's Genie 4 AI model, OpenAI's partnership with Google for custom chips, and interviews with industry leaders. Guests include Mark Gurman on Apple's product strategy, Zach Rash on autonomous delivery robots, Ben Liu on AI-driven drug development, Amiram Shachar on cloud and AI cybersecurity, and Jasper Zhang on GPU compute aggregation.

Notable Quotes

- Apple spent 20 years gaslighting people about not needing touchscreens, and then they did it. – Mark Gurman, on Apple's new touchscreen MacBook Pro.

- If you can only take three shots and hit a winner, you should probably sell. But if you can take more than 10 shots, your expected value changes entirely. – Ben Liu, on the economics of drug development.

- My coding time has dropped by 90%, but my review time is up by 600%. – Amiram Shachar, on the impact of AI on software development.

🍎 Apple's New Product Launches

- Mark Gurman shared insights from Apple's Pro and Tell event, highlighting the new touchscreen MacBook Pro with OLED display and the return of the iconic glowing Apple logo.

- Gurman praised the iPhone Duo for its foldable design but noted manufacturing defects, such as hinge issues causing screen cracks, and software quirks like the lack of picture-in-picture FaceTime.

- Apple's AI strategy was critiqued for lagging behind competitors like OpenAI and Google, with Siri's brand damage cited as a major hurdle.

🤖 Autonomous Delivery Robots by Coco Robotics

- Zach Rash discussed Coco Robotics' fleet of 1,000 sidewalk delivery robots and their expansion into the UK through a partnership with DoorDash and Deliveroo.

- The company plans to manufacture 20,000 next-gen robots by 2027, focusing on navigating complex urban environments and reducing operational costs through partnerships with merchants.

- Rash emphasized the importance of regulatory frameworks and shared benchmarks for AI performance in robotics.

💊 AI in Drug Development with Formation Bio

- Ben Liu explained how Formation Bio is addressing the bottleneck in drug development by acquiring discovered drugs and using AI to optimize clinical trials.

- The company’s $600 million fund will focus on individual drug assets, leveraging AI to match drugs with diseases and streamline trials.

- Liu highlighted the inefficiency of traditional drug development and the potential for AI to transform the industry by reducing costs and increasing throughput.

🛡️ Cybersecurity in the AI Era with Upwind

- Amiram Shachar introduced Upwind, a cybersecurity platform for cloud and AI infrastructure, which recently raised $400 million in a Series C round.

- The company’s unique approach stems from its founders’ expertise in cloud infrastructure rather than traditional cybersecurity, enabling them to address operational risks more effectively.

- Shachar discussed the challenges of vibe coding and the increasing need for robust cybersecurity as AI tools become more accessible to potential attackers.

💻 Aggregating Global Compute with Hyperbolic

- Jasper Zhang shared how Hyperbolic is building a unified platform to aggregate and orchestrate global GPU compute, allowing customers to access and resell capacity flexibly.

- The platform supports a wide range of hardware, from A100 GPUs to cutting-edge Blackwell chips, and aims to maximize revenue per GPU hour for users.

- Zhang, a math prodigy and UC Berkeley PhD graduate, emphasized the importance of creating an aggregation layer for the fragmented compute market.